0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Hypertension evaluation and management in new young patients: are we doing our female patients a disservice?

, , &
Article: 2387909 | Received 26 Jun 2024, Accepted 28 Jul 2024, Published online: 05 Aug 2024

References

  • Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health. 2019;16(7):1165. Available from: https://www.mdpi.com/1660-4601/16/7/1165/htm doi: 10.3390/ijerph16071165.
  • Eberly LA, Rusingiza E, Park PH, et al. Nurse-driven echocardiography and management of heart failure at District Hospitals in Rural Rwanda. Circ Cardiovasc Qual Outcomes. 2018;11(12):e004881. doi: 10.1161/circoutcomes.118.004881.
  • Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. doi: 10.1097/HJH.0000000000003480.Erratum in: J Hypertens. 2024 Jan 1;42(1):194.
  • Isakadze N, Mehta PK, Law K, et al. Addressing the gap in physician preparedness to assess cardiovascular risk in women: a comprehensive approach to cardiovascular risk assessment in women. Curr Treat Options Cardiovasc Med. 2019;21(9):47. doi: 10.1007/s11936-019-0753-0.
  • Burnier M, Brguljan J, Algharably EAE, et al. Women’s health, cardiovascular risk and hypertension: the perspective still needs to improve. Blood Press. 2023;32(1):2193648. doi: 10.1080/08037051.2023.2193648.
  • Cox JL, Zitner D, Courtney KD, et al. Undocumented patient information: an impediment to quality of care. Am J Med. 2003;114(3):211–216. doi: 10.1016/S0002-9343(02)01481-X.
  • Driscoll A, Beauchamp A, Lyubomirsky G, et al. Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women. Intern Med J. 2011;41(10):730–736. Oct doi: 10.1111/j.1445-5994.2011.02534.x.
  • Ferrannini G, De Bacquer D, Vynckier P, et al. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys. Cardiovasc Diabetol. 2021;20(1):38. doi: 10.1186/s12933-021-01233-6.
  • Charles L, Triscott J, Dobbs B. Secondary hypertension: Discovering the underlying cause. Am Fam Physician. 2017;96(7):453–461. Available from: https://pubmed.ncbi.nlm.nih.gov/29094913/
  • NHS inform. Menopause [Internet]. NHS Inform; 2024. Available from: https://www.nhsinform.scot/menopause.
  • European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics. 2012. Available from: https://www.escardio.org/static-file/Escardio/Press-media/press-releases/2013/EU-cardiovascular-disease-statistics-2012.pdf.
  • Al-Shidhani TA, Bhargava K, Rizvi S. An audit of hypertension at University Health Center in Oman. Oman Med J. 2011;26(4):248–252. doi: 10.5001/omj.2011.60.
  • Meagher PF, Deery C, Linton AF, et al. An audit of hypertensive care in general practice. Ir Med J. 1993;86(1):20–22. Available from: https://pubmed.ncbi.nlm.nih.gov/8444586/
  • Zhao M, Woodward M, Vaartjes I, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta‐analysis. J Am Heart Assoc. 2020;9(11):e014742. doi: 10.1161/JAHA.119.014742.
  • Lau ES, Paniagua SM, Guseh JS, et al. Sex differences in circulating biomarkers of cardiovascular disease. J Am Coll Cardiol. 2019;74(12):1543–1553. doi: 10.1016/j.jacc.2019.06.077.
  • Yahagi K, Davis HR, Arbustini E, et al. Sex differences in coronary artery disease: pathological observations. Atherosclerosis. 2015;239(1):260–267. doi: 10.1016/j.atherosclerosis.2015.01.017.
  • Garcia M, Mulvagh SL, Bairey Merz CN, et al. Cardiovascular disease in women. Circ Res. 2016;118(8):1273–1293. doi: 10.1161/CIRCRESAHA.116.307547.
  • Minhas AS, Ogunwole SM, Vaught AJ, et al. Racial disparities in cardiovascular complications with pregnancy-induced hypertension in the United States. Hypertension. 2021;78(2):480–488. doi: 10.1161/HYPERTENSIONAHA.121.17104.
  • Wright AK, Kontopantelis E, Emsley R, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation. 2019;139(24):2742–2753. doi: 10.1161/CIRCULATIONAHA.118.039100.
  • Tschiderer L, Seekircher L, Willeit P, et al. Assessment of cardiovascular risk in women: progress so far and progress to come. Int J Womens Health. 2023;15:191–212. doi: 10.2147/IJWH.S364012.
  • Kwan JL, Lo L, Ferguson J, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. doi: 10.1136/bmj.m3216.
  • Whelton PK, Flack JM, Jennings GL, et al. Editors’ commentary on the 2023 ESH management of arterial hypertension guidelines. AHA J. 2023;80(9):1795–1799. doi: 10.1161/HYPERTENSIONAHA.123.21592.